{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:47:23Z","timestamp":1760298443196},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.mehy.2011.11.011","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T00:40:47Z","timestamp":1323304847000},"page":"315-318","source":"Crossref","is-referenced-by-count":12,"title":["Is oral bisphosphonate-related osteonecrosis of the jaw an endemic condition?"],"prefix":"10.1016","volume":"78","author":[{"given":"P.","family":"Diz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Limeres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Seoane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Feijoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2011.11.011_b0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1196\/annals.1346.041","article-title":"Bisphosphonates: from bench to bedside","volume":"1068","author":"Russell","year":"2006","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"10.1016\/j.mehy.2011.11.011_b0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.mehy.2011.11.011_b0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/1566524023362104","article-title":"Bisphosphonate mechanism of action","volume":"2","author":"Rodan","year":"2002","journal-title":"Curr Mol Med"},{"issue":"Suppl 2","key":"10.1016\/j.mehy.2011.11.011_b0020","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1542\/peds.2006-2023H","article-title":"Bisphosphonates: mode of action and pharmacology","volume":"119","author":"Russell","year":"2007","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.mehy.2011.11.011_b0025","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00520-005-0913-5","article-title":"Bisphosphonates for malignancy-related bone disease: current status, future developments","volume":"14","author":"Body","year":"2006","journal-title":"Support Care Cancer"},{"issue":"8","key":"10.1016\/j.mehy.2011.11.011_b0150","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.14219\/jada.archive.2006.0355","article-title":"Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations","volume":"137","author":"American Dental Association Council on Scientific Affairs","year":"2006","journal-title":"J Am Dent Assoc"},{"issue":"Suppl 5","key":"10.1016\/j.mehy.2011.11.011_b0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.joms.2009.01.009","article-title":"American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.mehy.2011.11.011_b0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijom.2009.11.014","article-title":"Surgical management of bisphosphonate induced osteonecrosis of the jaws","volume":"39","author":"Williamson","year":"2010","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.mehy.2011.11.011_b0045","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3899\/jrheum.080759","article-title":"Canadian taskforce on Osteonecrosis of the Jaw. bisphosphonate associated osteonecrosis of the jaw","volume":"36","author":"Khan","year":"2009","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.mehy.2011.11.011_b0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Predicting risk of osteonecrosis of the jaw with oral bisphosphonate exposure (probe) investigators prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"10.1016\/j.mehy.2011.11.011_b0055","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1601-0825.2009.01568.x","article-title":"Bisphosphonate-related osteonecrosis: genetic and acquired risk factors","volume":"15","author":"Sarasquete","year":"2009","journal-title":"Oral Dis"},{"issue":"7","key":"10.1016\/j.mehy.2011.11.011_b0060","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","article-title":"Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis","volume":"112","author":"Sarasquete","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.mehy.2011.11.011_b0065","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2011.08622.x","article-title":"A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling","author":"Di Martino","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.mehy.2011.11.011_b0070","first-page":"579","article-title":"A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer","volume":"6","author":"English","year":"2010","journal-title":"Ther Clin Risk Manag"},{"issue":"8","key":"10.1016\/j.mehy.2011.11.011_b0075","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00432-010-0907-7","article-title":"Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases","volume":"136","author":"Filleul","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.mehy.2011.11.011_b0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcms.2010.05.009","article-title":"Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence - a multi-centre study","volume":"39","author":"Otto","year":"2011","journal-title":"J Craniomaxillofac Surg"},{"issue":"3","key":"10.1016\/j.mehy.2011.11.011_b0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijom.2010.11.002","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis","volume":"40","author":"Manfredi","year":"2011","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"12","key":"10.1016\/j.mehy.2011.11.011_b0090","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3899\/jrheum.090455","article-title":"Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients","volume":"36","author":"Favia","year":"2009","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.mehy.2011.11.011_b0095","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/039463201002300224","article-title":"Clinical experience with spiramycin in bisphosphonate-associated osteonecrosis of the jaw","volume":"23","author":"Gasparini","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2011.11.011_b0100","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.joms.2008.11.015","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients","volume":"67","author":"Lazarovici","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"10.1016\/j.mehy.2011.11.011_b0105","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-007-0384-2","article-title":"Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome","volume":"18","author":"Yarom","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.mehy.2011.11.011_b0170","unstructured":"Diniz M, L\u00f3pez Cedr\u00fan JL, Sanrom\u00e1n JF, Garc\u00eda A, Feijoo JF, Diz P. Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases in Spain. Med Oral Patol Oral Cir Bucal 2011, in press."},{"issue":"4","key":"10.1016\/j.mehy.2011.11.011_b0110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.stomax.2010.07.009","article-title":"Jaw osteonecrosis induced by oral biphosphonates: 12 cases","volume":"111","author":"Barrier","year":"2010","journal-title":"Rev Stomatol Chir Maxillofac"},{"issue":"5","key":"10.1016\/j.mehy.2011.11.011_b0115","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00198-009-1024-9","article-title":"Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia","volume":"21","author":"Hong","year":"2010","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.mehy.2011.11.011_b0120","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.joms.2009.04.067","article-title":"Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Kwon","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"12","key":"10.1016\/j.mehy.2011.11.011_b0125","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"issue":"9","key":"10.1016\/j.mehy.2011.11.011_b0130","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.joms.2010.05.003","article-title":"Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure","volume":"68","author":"Hutchinson","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.mehy.2011.11.011_b0165","unstructured":"Edwards BJ, editor. Merck Pharmaceuticals. Incidence rates of osteonecrosis of the jaw with alendronate. Chicago; 2006."},{"key":"10.1016\/j.mehy.2011.11.011_b0140","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0714.2010.01004.x","article-title":"Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws","author":"Arduino","year":"2011","journal-title":"J Oral Pathol Med"},{"issue":"9","key":"10.1016\/j.mehy.2011.11.011_b0145","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.joms.2009.04.032","article-title":"Bisphosphonate-induced avascular osteonecrosis of the mandible associated with a common thrombophilic mutation in the prothrombin gene","volume":"67","author":"Vairaktaris","year":"2009","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711005834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711005834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T11:04:58Z","timestamp":1561028698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987711005834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0306987711005834"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2011.11.011","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}